ICI plus doublet chemotherapy (64.9%) and ICI monotherapy (61.8%) had a similar SUCRA value, indicating that they are equally effective against NSCLC with high PD-L1 expression in terms of OS. Here, CD274 is linked to non-small cell lung carcinoma.